Thyroid dysfunction in chronic schizophrenia within a state psychiatric hospital

Annals of the Academy of Medicine Singapore

Volumn 31, Issue 5, 2002, Pages 641-644

  Sim, Kang ^b   Chong, S A ^c   Chan, Y H ^a   Lum, W M ^c  

^a MINISTRY OF HEALTH   (Singapore)

^b INSTITUTE OF MENTAL HEALTH   (Singapore)

^c NONE

Author keywords

Adults; Inpatients; Prevalence; Tests

Indexed keywords

THYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MENTAL HOSPITAL; MIDDLE AGED; PATHOPHYSIOLOGY; SCHIZOPHRENIA; THYROID FUNCTION TEST; THYROID GLAND;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES;

EID: 0036730715     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hall R C W. Psychiatric effects of thyroid hormone disturbance. Psychosomatics 1983; 24:7-18.
2. Lishman W A. Organic psychiatry: the psychological consequences of cerebral disorder. Oxford, Maiden, MA: Blackwell Science, 1998: 507-15.
3. Rupprecht R, Rupprecht C, Rupprecht M, Noder M, Mahlstedt J. Triiodothyronine, thyroxine and TSH response to dexamethasone in depressed patients and normal controls. Biol Psychiatry 1989; 25: 22-32.
4. Spratt D I, Pont A, Miller M B, McDougall I R, Bayer M F, McLaughlin W T. Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 1982; 73:41-8.
5. Martinos A, Rinieris P, Papachristou D N, Souvatzoglou A, Koutras D A, Stefanis C. Effects of six weeks neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients. Neuropsychobiology 1986; 16:72-7.
6. Braddock L, Blake I. Neuroendocrine tests during treatment with neuroleptic drugs, II: the TRH test. Br J Psychiatry 1981; 139:404-7.
7. Rao M L, Gross G, Strebel B, Braunig P, Huber G, Klosterkotter J. Serum amino acids, central monoamines and hormones in drug-naïve, drug-free and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 1990; 34:243-57.
8. Magliozzi J R, Gold A, Laubly J N. Effect of oral administration of haloperidol on plasma thyrotropin concentrations in man. Psychoneuroendocrinology 1989; 14:125-30.
9. th ed. Washington: American Psychiatric Association, 1994.
10. Overall J E. The brief psychiatric rating scale. Psychol Rep 1962; 10:799-812.
11. Davis J M. Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 1976; 33:858-61.
12. Othman S S, Abdul Kadir K, Hassan J, Hong G K, Singh B B, Raman N. High prevalence of thyroid function test abnormalities in chronic schizophrenia. Aust N Z J Psychiatry 1994; 28:620-4.
13. Morley J E, Shafer R B. Thyroid function screening in new psychiatric admissions. Arch Intern Med 1982; 142:591-3.
14. Spratt D I, Pont A, Miller M B, McDougall I R, Bayer M F, McLaughlin W T. Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 1982; 73:41-8.
15. Siris S G, Frechen K, Strahan A, Cutler J, Owen K, Alvir J, et al. Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 369-78.
16. Langer G, Resch F, Aschauer H, Keshavan M S, Koinig G, Schonbeck G, et al. TSH response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs. Neuropsychobiology 1984; 11:213-8.
17. Langer G, Koinig G, Hatzinger R, Schonbeck G, Resch F, Aschauer H, et al. Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome. Prediction of recovery and relapse in treatment with antidepressants and neuroleptics. Arch Gen Psychiatry 1986; 43:861-8.
18. Beasley C M, Magnusson M, Garver D L. TSH response to TRH and haloperidol response latency in psychoses. Biol Psychiatry 1988; 24:423-31.
19. De Milo L. TRH response pattern in adolescent schizophrenic males. Br J Psychiatry 1984; 145:649-51.
20. Baumgartner A, Pietzcker A, Gaebel W. The hypothalamic-pituitary-thyroid axis in patients with schizophrenia. Schizophrenia Res 2000; 44:233-43.
21. Reynolds G P. Increased concentration and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 1983; 305:527-9.
22. Seeman P, Van Tol H M. Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 1993; 6:602-8.
23. Collu R, Jequier J C, Leboeuf G, Letarte J, Ducharme J R. Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 1975; 41:981-4.
24. Naber D, Steinbock H, Greil W. Effects of short and long term neuroleptic treatment on thyroid fuction. Prog Neuropsychopharmacol Biol Psychiatry 1980; 4:199-206.
25. Magliozzi J R, Gold A, Laubly J N. Effect of oral administration of haloperidol on plasma thyrotropin concentrations in man. Psychoneuroendocrinology 1989; 14:125-30.
26. Owen F, Cross A J, Crow T J, Longden A, Poulter M, Riley G J. Increased dopamine receptor sensitivity in schizophrenia. Lancet 1978; ii:223-5.
27. Fersguson B, Dudleston K. Detection of physical disorder in newly admitted psychiatric inpatients. Acta Psychiatr Scand 1986; 74:485-9.
28. White A J, Barraclough B. Thyroid disease in psychiatric admissions. J Psychosom Res 1988; 32:99-106.
29. Enns M, Ross C, Clark P. Thyroid screening tests in psychiatric inpatients. Gen Hosp Psychiatry 1992; September; 14:334-9.
30. Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalised patients. Arch Intern Med 1999; 159:658-65.
31. Levy R P, Jensen J B, Laus V B, Agle D P, Engel I M. Serum thyroid abnormality in psychiatric disease. Metabolism 1981; 30:1060-4.